INmune Bio, Inc. (INMB)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Apr 02, 16:00
1.215
0.00 (0.00%)
After-Hours: 20:00
INmune Bio Market Cap : 31.78M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AngioDynamics, Inc. | 366.94M |
| Omeros Corp. | 696.69M |
| Precipio, Inc. | 44.06M |
| PDS Biotechnology Corp. | 36.97M |
| Sangamo Therapeutics, Inc. | 143.87M |
Market Cap Related Metrics
| PS Ratio | 598.74 |
| Price to Book Value | 1.368 |
| Price | 1.21 |
| Earnings Yield | -159.0% |